Synapse Biomedical Wins New Approval for Diaphragm Pacing System to Free Patients from Ventilators

Ruling will make device more affordable and accessible for those with spinal cord injuries OBERLIN, Ohio, April 5, 2023 /PRNewswire/ — Synapse Biomedical, Inc. announced today that the FDA has granted premarket approval (PMA) of the NeuRx® Diaphragm Pacing System (NeuRx DPS®) for use in…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.